Integra LifeSciences Holdings Corporation has announced the launch of the Integra® CUSA® NXT Inferior Forward Bone Tip for its CUSA® NXT Ultrasonic Tissue Ablation System.
Integra says over 2,000 centres worldwide rely on its CUSA® ultrasonic surgical ablation technology for a variety of procedures, including the removal of tissues associated with brain and abdominal tumours. The company currently offers a diverse line of CUSA® products, including the CUSA® NXT, CUSA® Excel+, CUSA® Excel, CUSA® Selector®, and CUSA® Dissectron™ systems.
The CUSA® NXT system is a well-recognised medical device used in neurosurgical and other surgical procedures for the controlled and selective removal of soft tissue and bone near critical structures. The Integra® CUSA® NXT Bone Tips have now received 510(k) clearance from the U.S. FDA.
The new Integra® CUSA® NXT Inferior Forward Bone Tip expands the surgical applications for the CUSA® NXT system. The newest tip in the family features a working surface that is oriented towards the inferior surface of the tip, making it useful in situations where the surgical setting requires downward pressure for bone removal.
“We are excited to expand the tip selection for Integra’s CUSA® NXT platform,” said Bob Davis, President of Integra’s Neurosurgery business. “The orientation of the new tip will help neurosurgeons during cases when they are approaching the bone from above. The tip also generates less heat than competitive devices, which can be very important in certain surgical procedures.”
Source: Integra Lifesciences Holdings Corporation, Globe Newswire